» Articles » PMID: 27499849

Recent Advances in Phototherapy for Psoriasis

Overview
Journal F1000Res
Date 2016 Aug 9
PMID 27499849
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Phototherapy involves repeated exposure of the skin to ultraviolet light to treat various inflammatory skin conditions such as psoriasis. Recent studies have identified specific immunologic effects of phototherapy that may underlie phototherapy efficacy. Furthermore, recent advancements have been made in developing safe and effective targeted phototherapy modalities for difficult-to-treat areas such as scalp psoriasis. Targeted phototherapy in the form of the excimer laser holds potential for more aggressive, effective treatment and long-lasting remission of psoriasis. Phototherapy is now also used successfully with biologic agents as combination therapy to treat recalcitrant psoriasis. Therefore, though one of the oldest therapeutic modalities for psoriasis, phototherapy remains a mainstay treatment with promise for further advancement.

Citing Articles

Lipid-based nanoparticles for psoriasis treatment: a review on conventional treatments, recent works, and future prospects.

Mohd Nordin U, Ahmad N, Salim N, Mohd Yusof N RSC Adv. 2022; 11(46):29080-29101.

PMID: 35478537 PMC: 9038133. DOI: 10.1039/d1ra06087b.


Phototherapy.

Barros N, Sbroglio L, Buffara M, Baka J, Pessoa A, Azulay-Abulafia L An Bras Dermatol. 2021; 96(4):397-407.

PMID: 33849754 PMC: 8245715. DOI: 10.1016/j.abd.2021.03.001.


Home Narrowband Ultraviolet B Phototherapy for Photoresponsive Skin Conditions: A Health Technology Assessment.

Ont Health Technol Assess Ser. 2020; 20(12):1-134.

PMID: 33240453 PMC: 7668536.


Unexpected dose response of HaCaT to UVB irradiation.

Chang R, Chen C, Huang C, Chang C, Cui Y, Chung W In Vitro Cell Dev Biol Anim. 2018; 54(8):589-599.

PMID: 30083841 DOI: 10.1007/s11626-018-0280-4.


T cell-intrinsic prostaglandin E-EP2/EP4 signaling is critical in pathogenic T17 cell-driven inflammation.

Lee J, Aoki T, Thumkeo D, Siriwach R, Yao C, Narumiya S J Allergy Clin Immunol. 2018; 143(2):631-643.

PMID: 29935220 PMC: 6354914. DOI: 10.1016/j.jaci.2018.05.036.

References
1.
Feldman S, Mellen B, Housman T, Fitzpatrick R, Geronemus R, Friedman P . Efficacy of the 308-nm excimer laser for treatment of psoriasis: results of a multicenter study. J Am Acad Dermatol. 2002; 46(6):900-6. DOI: 10.1067/mjd.2002.120454. View

2.
Chen X, Yang M, Cheng Y, Liu G, Zhang M . Narrow-band ultraviolet B phototherapy versus broad-band ultraviolet B or psoralen-ultraviolet A photochemotherapy for psoriasis. Cochrane Database Syst Rev. 2013; (10):CD009481. PMC: 11076274. DOI: 10.1002/14651858.CD009481.pub2. View

3.
Wolf P, Hofer A, Weger W, Posch-Fabian T, Gruber-Wackernagel A, Legat F . 311 nm ultraviolet B-accelerated response of psoriatic lesions in adalimumab-treated patients. Photodermatol Photoimmunol Photomed. 2011; 27(4):186-9. DOI: 10.1111/j.1600-0781.2011.00594.x. View

4.
Wong T, Hsu L, Liao W . Phototherapy in psoriasis: a review of mechanisms of action. J Cutan Med Surg. 2013; 17(1):6-12. PMC: 3736829. DOI: 10.2310/7750.2012.11124. View

5.
Calzavara-Pinton P, Sala R, Arisi M, Rossi M, Venturini M, Ortel B . Synergism between narrowband ultraviolet B phototherapy and etanercept for the treatment of plaque-type psoriasis. Br J Dermatol. 2013; 169(1):130-6. DOI: 10.1111/bjd.12277. View